Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02276963
Brief Title: Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

First Submitted : October 21, 2014
First Submitted that Met QC Criteria : October 27, 2014
First Posted : October 28, 2014 (Estimate)

Results First Submitted : February 22, 2019
Results First Submitted that Met QC Criteria : June 5, 2019
Results First Posted : June 6, 2019

Last Update Submitted that Met QC Criteria : June 5, 2019
Last Update Posted : June 6, 2019